SPY Stock Analysis 27JUL23

Invitation to Cosmo’s Half-Year 2023 Webcast on 26 July 2023 – Biotech Investments

Cosmo Pharmaceuticals N.V. / Key word(s): Half Year Results Invitation to Cosmo’s Half-Year 2023 Webcast on 26 July 2023 05.07.2023 / 06:15 GMT/BST Dublin, Ireland

July 6, 2023

Kezar stalls solid tumour trial to focus on autoimmune disease candidate – Pharmaceutical Technology

Enrolment into the Phase I trial investigating Kezar’s solid tumour drug KZR-261 has been halted. Credit: PeopleImages.com – Yuri A via Shutterstock. Clinical stage biopharma

August 14, 2024

Merck and GTRI to produce gene therapy for Parkinson’s disease

Merck signed a non-binding MoU with the Gene Therapy Research Institution. Credit: Merck KGaA, Darmstadt, Germany and/or its affiliates. German company Merck kGaA has entered

July 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.